Kim Branson — SPARQNOW

At-a-Glance

Serves as Chief AI Officer at GSK, leading a global team of engineers, data scientists, and machine learning researchers.
Pioneers data-driven approaches to improve drug discovery and development at GSK.
Focuses on unlocking the potential of complex genetic data using cross-discipline expertise and collaborations.
Aims to double the development success rate for medicines and vaccines at GSK.
Previous work included large-scale machine learning and medical informatics initiatives, from computational drug design to disease risk prediction.

Biography

Kim Branson is the Chief AI Officer at GSK, where he leads a global team of engineers, data scientists, and machine learning researchers. In this role, he pioneers a data-driven approach to improve drug discovery and development. He is passionate about modeling, machine learning, and the application of deep learning methods in drug development. At GSK.